83 related articles for article (PubMed ID: 15547752)
1. Gene expression in response to anti-tumour intervention by polysaccharide-K (PSK) in colorectal carcinoma cells.
Yoshikawa R; Yanagi H; Hashimoto-Tamaoki T; Morinaga T; Nakano Y; Noda M; Fujiwara Y; Okamura H; Yamamura T
Oncol Rep; 2004 Dec; 12(6):1287-93. PubMed ID: 15547752
[TBL] [Abstract][Full Text] [Related]
2. ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.
Yoshikawa R; Yanagi H; Shen CS; Fujiwara Y; Noda M; Yagyu T; Gega M; Oshima T; Yamamura T; Okamura H; Nakano Y; Morinaga T; Hashimoto-Tamaoki T
World J Gastroenterol; 2006 Sep; 12(36):5884-9. PubMed ID: 17007058
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound polysaccharide K reduced the invasive ability of colon cancer cell lines.
Uwafuji S; Goi T; Naruse T; Kurebayashi H; Nakazawa T; Hirono Y; Yamaguchi A
Anticancer Res; 2013 Nov; 33(11):4841-5. PubMed ID: 24222121
[TBL] [Abstract][Full Text] [Related]
5. [Differences in gene expression profile between high and low metastatic human colorectal cancer cell lines].
Weng DS; Ding YQ; Sun Q
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):256-9. PubMed ID: 15041535
[TBL] [Abstract][Full Text] [Related]
6. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
7. The expression of integrins is decreased in colon cancer cells treated with polysaccharide K.
Aso K; Goi T; Nakazawa T; Kimura Y; Hirono Y; Katayama K; Yamaguchi A
Int J Oncol; 2013 Apr; 42(4):1175-80. PubMed ID: 23427003
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview.
Kobayashi H; Matsunaga K; Oguchi Y
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):275-81. PubMed ID: 7606203
[TBL] [Abstract][Full Text] [Related]
9. Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT.
Chunhua L; Donglan L; Xiuqiong F; Lihua Z; Qin F; Yawei L; Liang Z; Ge W; Linlin J; Ping Z; Kun L; Xuegang S
J Nutr Biochem; 2013 Oct; 24(10):1766-75. PubMed ID: 23773626
[TBL] [Abstract][Full Text] [Related]
10. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer.
Huang MY; Wang JY; Chang HJ; Kuo CW; Tok TS; Lin SR
Oncol Rep; 2011 May; 25(5):1297-306. PubMed ID: 21344162
[TBL] [Abstract][Full Text] [Related]
11. Protein-bound polysaccharide-K (PSK) directly enhanced IgM production in the human B cell line BALL-1.
Maruyama S; Akasaka T; Yamada K; Tachibana H
Biomed Pharmacother; 2009 Jul; 63(6):409-12. PubMed ID: 18848763
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the mechanism of apoptosis induction by PSK].
Hirahara N; Fujioka M; Fujieda A; Wada T; Tanaka T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2255-7. PubMed ID: 21224539
[TBL] [Abstract][Full Text] [Related]
13. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
14. Polysaccharide-K (PSK) in cancer--old story, new possibilities?
Sun C; Rosendahl AH; Wang XD; Wu DQ; Andersson R
Curr Med Chem; 2012; 19(5):757-62. PubMed ID: 22204346
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.
Koehler A; Bataille F; Schmid C; Ruemmele P; Waldeck A; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2004 Sep; 204(1):65-74. PubMed ID: 15307139
[TBL] [Abstract][Full Text] [Related]
16. [Study on radiation sensitivity of colorectal cancer cells using gene expression profile].
Yang XD; Xing CG; Gong W; Zhou LY; Wu YY; Zhao K
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):371-3. PubMed ID: 19598022
[TBL] [Abstract][Full Text] [Related]
17. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
18. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.
Clemo NK; Collard TJ; Southern SL; Edwards KD; Moorghen M; Packham G; Hague A; Paraskeva C; Williams AC
Carcinogenesis; 2008 Apr; 29(4):849-57. PubMed ID: 18204076
[TBL] [Abstract][Full Text] [Related]
19. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
